Imperative Care Announces the Launch of Its Zoom POD™ for Stroke Treatment, the First and Only Filter to Capture Clot in the Sterile Field

Newest addition to company’s Zoom Stroke Solution allows for quick confirmation of successful clot retrieval during mechanical thrombectomy for ischemic stroke

CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced the launch of its Zoom POD™ Aspiration Tubing, the company’s latest innovation in elevating stroke care. The Zoom POD is the newest addition to Imperative Care’s Zoom Stroke Solution™, the company’s ischemic stroke product portfolio that includes the Zoom 88 Large Distal Platform for neurovascular access, four Zoom Aspiration Catheters in various sizes, and the Zoom Pump with accessories.

The Zoom POD is the first and only sterile field clot filter device, enabling faster time to clot capture during critical mechanical thrombectomy procedures for ischemic stroke patients. The Zoom POD is integrated into the aspiration tubing, shortening the distance from aspiration to filtration while maintaining full aspiration power. Positioned within the sterile field, the physician can immediately see the clot as it is extracted from the patient, quickly confirming clot capture and giving the physician more control over the mechanical thrombectomy procedure.

“At Imperative Care, we are keenly focused on physician feedback, working to innovate the stroke procedure from all angles to continuously improve patient outcomes,” said Daniel Davis, President and COO of Imperative Care. “We are committed to providing value not only with our advanced catheters but also by innovating and optimizing each component of the Zoom Stroke Solution. The Zoom POD simplifies and speeds up a critical part of the procedure, providing an immediate visual in the hands of the physician, and confirming successful retrieval of the clot.”

“Stroke care is all about speed. In order to achieve the best possible outcomes for patients, it’s imperative to retrieve the clot from the brain quickly. The Zoom POD will allow physicians like myself to visually confirm immediately, right within the sterile field, that the clot has been captured,” said Shahid Nimjee, M.D., Ph.D., vascular neurosurgeon and associate professor at The Ohio State University Wexner Medical Center. “Additionally, the ability to capture the clot in the Zoom POD allows me to easily take the clot back to the pathology lab, break it down, and analyze it.”

About the Zoom Stroke Solution

The Zoom Stroke Solution is the complete stroke system from access through reperfusion for fast and effective clot removal for patients with acute ischemic stroke. The system includes the Zoom 88 Large Distal Platform for neurovascular access, four vessel-matched Zoom Aspiration Catheters, the Zoom Pump, the Zoom POD and accessories. All Zoom catheters are designed with the TRX™ Tip which provides 15% greater clot engagement area at the tip of the catheter and are designed to enable smooth tracking through challenging vasculature. For complete product information, including indications, contraindications, warnings, precautions and adverse events visit: http://bit.ly/2Vx0Qcf

About Imperative Care, Inc.

Imperative Care is a medical technology company focused on developing the next generation of innovative solutions to address the vast and urgent needs in stroke intervention and peripheral thrombectomy. The company has two 510(k) cleared product platforms, as well as an expansive stroke technology development pipeline. In addition, Imperative Care’s wholly owned subsidiary Truvic is developing solutions for the treatment of peripheral vascular disease. Imperative Care and Truvic are based in Campbell, Calif. https://imperativecare.com

Contacts

Investor Contact:
Matt Garrett, CFO

Imperative Care, Inc.

408-476-1672

mgarrett@imperativecare.com

Media Contact:
Lara Lingenbrink

Imperative Care, Inc.

858-525-1414

llingenbrink@imperativecare.com